Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology and Therapy
Published in: Rheumatology and Therapy 1/2018

Open Access 01-06-2018 | Commentary

Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives

Authors: Shelly Heath-Watson, Sangeeta Sule

Published in: Rheumatology and Therapy | Issue 1/2018

Login to get access

Abstract

This article, co-authored by a parent of a child with juvenile idiopathic arthritis (JIA) and his pediatric rheumatologist, discusses the parent’s experience of having a child with JIA from diagnosis through living day-to-day with the disease.
Literature
1.
David J, Cooper C, Hickey L, et al. The functional and psychological outcomes of juvenile chronic arthritis in young adulthood. Br J Rheumatol. 1994;33:876–81.CrossRefPubMed
2.
Knafl K, Leeman J, Havill N, et al. The contribution of parent and family variables to the well-being of youth with arthritis. J Fam Nurs. 2015;21:579–616.CrossRefPubMed
Metadata
Title
Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives
Authors
Shelly Heath-Watson
Sangeeta Sule
Publication date
01-06-2018
Publisher
Springer Healthcare
Published in
Rheumatology and Therapy / Issue 1/2018
Print ISSN: 2198-6576
Electronic ISSN: 2198-6584
DOI
https://doi.org/10.1007/s40744-018-0098-2

Other articles of this Issue 1/2018

Rheumatology and Therapy 1/2018 Go to the issue

Review

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases

Original Research

Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data

Original Research

Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

Original Research

Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis

Brief Report

Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis

Case Report

A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits